ELTX · CIK 0001601485 · operating
Elicio Therapeutics, Inc. (ELTX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $189 million, Elicio Therapeutics, Inc. is a micro-cap company. The stock currently trades at $13.82, up 6.39% today, with a 52-week range of $4.60–$12.62.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-4.25 | $-4.25 | +38.9% | |
| 2023 | $-6.96 | $-6.96 | -439.5% | |
| 2022 | $-1.29 | $-1.29 | +33.2% | |
| 2021 | $-1.93 | $-1.93 | — |